Crown Castle (CCI)
NYSEReal EstateReit - SpecialtySnapshot 2026-10-30
$88.69-0.16%
Close 2026-10-30 · 1-day change
NYSEReal EstateReit - SpecialtySnapshot 2026-10-30
Research Workspace
Put CCI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Real Estate is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Achieve EPS near $1.94: Diluted EPS: $0.67 per share.
View ThesisRevenue is contracting — down about 15% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 16%.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskCCI’s case rests on operating efficiencies, though recent financial performance has weakened. Revenue fell year over year in both reported quarters; the latest print beat by 7%. CCI trades at 25× P/FFO versus a 12× peer median. The market prices in more growth than our forecast, leaving expectations full. Diluted EPS was $0.67 against a primary pillar near $1.94. The next-quarter miss probability is 26%. Peer multiples imply a price about 14% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-30. CCI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering CCI (as of Oct 2026).
Based on 3 Wall Street analysts offering 12-month price targets for CCI in the last 4 months.
Continue this research
Compare CCI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CCI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-10-30. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Real Estate (broad) — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CCI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Drive operating efficiencies and reduce annualized costs by $65 million
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
Current $88.69
The last 12 months of price, then the range of analyst 12-month targets from today’s $88.69.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Higher 2026 EBITDA outlook and targeted margin expansion support the cost-efficiency objective.
New leadership role may enhance strategic execution.